Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Ganglioglioma
ADR ID BADD_A09941
ADR Hierarchy
17      Nervous system disorders
17.20      Nervous system neoplasms malignant and unspecified NEC
17.20.01      Nervous system neoplasms unspecified malignancy NEC
17.20.01.011      Ganglioglioma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.30      Nervous system neoplasms malignant and unspecified NEC
16.30.01      Nervous system neoplasms unspecified malignancy NEC
16.30.01.011      Ganglioglioma
Description Rare indolent tumors comprised of neoplastic glial and neuronal cells which occur primarily in children and young adults. Benign lesions tend to be associated with long survival unless the tumor degenerates into a histologically malignant form. They tend to occur in the optic nerve and white matter of the brain and spinal cord. [MeSH]
MedDRA Code 10017701
MeSH ID D018303
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Ganglioglioma | Gangliogliomas | Ganglioglioma, Intracranial | Gangliogliomas, Intracranial | Intracranial Ganglioglioma | Intracranial Gangliogliomas | Ganglioglioma, Malignant | Gangliogliomas, Malignant | Malignant Ganglioglioma | Malignant Gangliogliomas | Ganglioglioma, Benign | Benign Ganglioglioma | Benign Gangliogliomas | Gangliogliomas, Benign
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00364Carboplatin0.000112%
BADD_D00566Dabrafenib0.000112%
BADD_D02257Trametinib0.000112%
The 1th Page    1    Total 1 Pages